Part 3 — Final 

Failure to Meet Safeguarding and Governance Standards

The 2026 assessment did not meet the safeguarding or governance standards required when assessing a vulnerable adult with a known neurological visual impairment. Safeguarding is not limited to protection from abuse — it includes ensuring that clinical information is accurate, appropriate, and safe to rely upon.

By using the wrong framework, omitting essential tests, misinterpreting neurological features, and contradicting the long‑term record, the 2026 assessment created avoidable risk and produced a clinical letter that is not safe for other professionals to use.

Safeguarding requires accurate and appropriate assessment

Safeguarding frameworks expect clinicians to:

• recognise vulnerability

• understand the nature of the impairment

• use appropriate clinical methods

• identify functional‑vision risk

• ensure the record reflects the true level of need

The 2026 assessment did not meet these expectations.

Instead, it:

• minimised the impairment

• misrepresented neurological features

• obscured functional‑vision risk

• contradicted the established baseline

• created a misleading clinical narrative

This is a safeguarding failure because inaccurate information leads to unsafe decisions.

Failure to recognise the young person’s vulnerability

The young person has:

• a lifelong neurological impairment

• permanent functional‑vision limitations

• documented spatial‑awareness deficits

• a history of risk in real‑world environments

These factors place them within a vulnerable‑adult safeguarding category.

The 2026 assessment did not acknowledge this vulnerability. It treated the appointment as a routine sight test, rather than a specialist assessment with safeguarding implications.

Failure to ensure the record was safe for other professionals

The 2026 letter is used by:

• support workers

• social‑care professionals

• mobility specialists

• education or employment services

• other clinicians

If the record is inaccurate, these professionals may:

• underestimate risk

• reduce support

• assume independence

• make unsafe decisions

• misunderstand the impairment

A clinical letter that misrepresents a permanent neurological condition as “intermittent” is not safe to rely upon.

This is a governance failure.

Failure to maintain continuity of care

Governance standards require:

• consistency between assessments

• reference to the long‑term record

• justification for any deviation

• accurate documentation of permanent conditions

The 2026 assessment:

• contradicted the 30‑year baseline

• did not reference previous specialist findings

• did not justify the contradictions

• created a new, inaccurate narrative

This breaks continuity of care and undermines clinical safety.

Failure to meet professional

&

Organisational governance standards

Governance frameworks require clinicians to:

• use appropriate methods

• document accurately

• avoid misleading information

• recognise the limits of routine testing

• escalate when specialist assessment is required

The 2026 assessment did not meet these standards.

Instead, it:

• used an inappropriate framework

• omitted essential tests

• misinterpreted neurological features

• produced unsupported conclusions

• failed to recognise safeguarding implications

These are governance failures, not clinical disagreements.

Why this matters

When a vulnerable adult is assessed using the wrong methods, and the resulting letter:

• contradicts the established baseline

• misrepresents permanent impairments

• minimises functional‑vision needs

• obscures risk

• lacks clinical justification

the assessment becomes unsafe, and the record becomes unreliable.

The 2026 assessment did not meet the safeguarding or governance standards required for safe clinical practice.

The safeguarding and governance failures identified in Part 3 show that the 2026 assessment was not clinically safe or procedurally valid. Part 4 examines how these failures affected the accuracy, reliability, and professional use of the 2026 clinical letter.

Next Part 4 — Why the 2026 Letter Cannot Be Relied Upon

Design & Copyright Owner Maureen Booth-Martin (MBM) © All rights reserved.